Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Thermo Fisher Scientific
56 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
PAO-01-23-RT-01
Decentralized Clinical Trial Design
Reducing the Challenges Sites Face when Implementing Decentralized Trials
PAO-11-022-CL-05
Facility Expansion
Thermo Fisher Scientific Expands Millersburg, Pa. Bioprocessing Manufacturing Site
PR-M02-22-14
Personalized and Precision Medicine
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
PAO-12-21-RT-01
M&A
Thermo Fisher Scientific Acquires PPD and Leverages Clinical
PAO-06-21-MA-01
Cell Therapy Manufacturing
Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center
PR-M05-21-017
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
M&A
Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
PR-M04-21-016
Acquisition
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
PR-M11-20-035
Termination
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
PR-M08-20-NI-21
Partnership
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
PR-M06-20-NI-023
Partnership
Thermo Fisher Scientific and CSL Enter Strategic Partnership
PR-M05-20-NI-040
Diagnostic Testing
Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
PR-M05-20-NI-017
COVID-19
Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19
PR-M03-20-NI-046
AAV Vector Production
Challenges to Process Validation for Viral Vectors
PAP-Q1-20-CL-002
M&A
Thermo Fisher Scientific to Acquire QIAGEN N.V.
PR-M03-20-NI-009
Partnership
Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages
PR-M01-20-NI-027
Funding
Arranta Bio Announces $82M in New Funding, and a Strategic Partnership with Thermo Fisher Scientific
PR-M10-19-NI-044
AAV Vector Production
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems
PAP-Q3-19-CL-006
M&A
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
PR-M05-19-NI-051
M&A
Brammer Bio Purchased by Thermo Fisher Scientific
PAO-M03-19-NI-032
Award
Thermo Fisher Scientific Instruments Recognized by SelectScience
PR-M03-19-NI-071
Acquistion
Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing
PR-M03-19-NI-078
Market Expansion
Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities
PR-M03-19-NI-056
1
3
»
